Kewpie first developed Sodium hyaluronate in 1983 and is currently the leading Japanese manufacturer of pharmaceutical grade Sodium hyaluronate used as an API and pharmaceutical excipients.
Its Sodium hyaluronate is suitable for dermal fillers, knee injections, eye drops and external preparations. Kewpie exports Sodium hyaluronate to over 30 countries.
Its pharmaceutical grade Sodium hyaluronate (Hyaluronic acid) is manufactured under strict regulations at its factory near Tokyo .
Its R&D team has been developing new technologies related to Sodium Hyaluronate for a long time.